endotelio

PHARMENA SA is a dynamically-developing, public limited biotechnology company. Our main line of business is development and commercialization of innovative products based on a patented physiological and natural active ingredient – 1‑MNA.

The Company’s business concentrates on clinical trials of this innovative anti-inflammatory and anti-fibrotic drug and implementation on the market innovative dietary supplements used to satisfy special dietary needs.